Editas Medicine (EDIT) Return on Sales (2015 - 2025)
Editas Medicine (EDIT) reported Return on Sales of 0.03% for Q3 2025, up 1015.0% year-over-year from 0.0% in Q3 2024, and up 76.86% on a QoQ basis from 0.14% in Q2 2025.
Editas Medicine (EDIT) has 11 years of Return on Sales data on file, last reported at 0.03% in Q3 2025.
- Quarterly Return on Sales rose 1015.0% year-over-year to 0.03% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.04% (down 1.0% YoY) and the FY2024 annual result came in at 0.07%, down 5.0% from the prior year.
- Return on Sales rose to 0.03% in Q3 2025 per EDIT's latest filing, from 0.14% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q4 2023 and bottomed at 13.27% in Q3 2022.
- The 5-year median for Return on Sales is 0.09% (2021), against an average of 1.47%.
- The widest annual swing landed in 2022, when Return on Sales tumbled 1321 bps; it then soared 1318 bps in 2023.
- Tracing EDIT's Return on Sales over 5 years: stood at 0.03% in 2021, then slumped by 180 bps to 0.09% in 2022, then soared by 97 bps to 0.0% in 2023, then tumbled by 372 bps to 0.01% in 2024, then slumped by 124 bps to 0.03% in 2025.
- Per Business Quant, the three latest EDIT Return on Sales figures stand at 0.03% (Q3 2025), 0.14% (Q2 2025), and 0.16% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.00% |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.14% |
| Mar 31, 2025 | -0.16% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -10.19% |
| Jun 30, 2024 | -1.32% |
| Mar 31, 2024 | -0.55% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -0.14% |
| Mar 31, 2023 | -0.05% |
| Dec 31, 2022 | -0.09% |
| Sep 30, 2022 | -13.27% |
| Jun 30, 2022 | -0.08% |
| Mar 31, 2022 | -0.07% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -0.06% |
| Jun 30, 2021 | -1.46% |
| Mar 31, 2021 | -0.09% |
| Dec 31, 2020 | -0.06% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -0.03% |
| Mar 31, 2020 | -0.08% |
| Dec 31, 2019 | -0.03% |
| Sep 30, 2019 | -0.09% |
| Jun 30, 2019 | -0.14% |
| Mar 31, 2019 | -0.14% |
| Dec 31, 2018 | -0.04% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -0.05% |
| Mar 31, 2018 | -0.08% |
| Dec 31, 2017 | -0.06% |
| Sep 30, 2017 | -0.04% |
| Jun 30, 2017 | -0.09% |
| Mar 31, 2017 | -0.46% |
| Dec 31, 2016 | -0.44% |
| Sep 30, 2016 | -0.22% |
| Jun 30, 2016 | -0.06% |
| Mar 31, 2016 | -0.22% |
| Dec 31, 2015 | -0.16% |
| Sep 30, 2015 | -0.11% |
| Jun 30, 2015 | -0.62% |